Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia Meeting Abstract
| Authors: | Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Kim, E.; Saven, A.; Wadleigh, M.; Stone, R. M.; Barrientos, J. C.; Rai, K. R.; Grever, M. R.; Altman, J. K.; Lacouture, M. E.; Rosen, N.; Berger, M.; Levine, R. L.; Abdel-Wahab, O.; Tallman, M. S. |
| Abstract Title: | Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349233803022 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.24.24 |
| Notes: | Meeting Abstract: 24 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
